High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia
Gespeichert in:
| Veröffentlicht in: | Clinical rheumatology 2020-07, Vol.39 (7), p.2095-2097 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2097 |
|---|---|
| container_issue | 7 |
| container_start_page | 2095 |
| container_title | Clinical rheumatology |
| container_volume | 39 |
| creator | Gazzaruso, Carmine Carlo Stella, Nicoletta Mariani, Giuseppe Nai, Carlo Coppola, Adriana Naldani, Daniela Gallotti, Pietro |
| description | |
| doi_str_mv | 10.1007/s10067-020-05180-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7251560</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2413236276</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-d7da2bff891e3a81c39d86e0e2e160461bbd1b4caa31847d3a01ae8d837f837b3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi0EokvhD3BAlrhwCYw_EjsXpGpFKVKlSi1wtZx4susqawc7qQS_vma3FMqhB9sjzzPvzOgl5DWD9wxAfcjlblQFHCqomYZKPSErJoWs2la2T8kKlIJKsFYfkRc5XwMA1y17To4Elw2XvF6RdOY3WzolvLEjhh5pHKgNsw9LP6JN-7iLzmMuoaPjMi15_9lHu1nGElEf6GRnj2HOdBvz5Gc7-l_o6BATvTq5vKrW8TunU8BlF4O3L8mzwY4ZX929x-Tb6aev67Pq_OLzl_XJedVLJefKKWd5NwxlYhRWs160TjcIyJE1IBvWdY51srdWMC2VExaYRe20UEM5nTgmHw-609Lt0PVlwGRHMyW_s-mnidabh5ngt2YTb4ziNasbKALv7gRS_LFgns3O5x7HsjXGJRsuQdVaQKML-vY_9DouKZT1CsUEFw1XTaH4gepTzDnhcD8MA_PbUnOw1BRLzd5So0rRm3_XuC_542EBxAHIJRU2mP72fkT2FlkjrrU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2413236276</pqid></control><display><type>article</type><title>High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Gazzaruso, Carmine ; Carlo Stella, Nicoletta ; Mariani, Giuseppe ; Nai, Carlo ; Coppola, Adriana ; Naldani, Daniela ; Gallotti, Pietro</creator><creatorcontrib>Gazzaruso, Carmine ; Carlo Stella, Nicoletta ; Mariani, Giuseppe ; Nai, Carlo ; Coppola, Adriana ; Naldani, Daniela ; Gallotti, Pietro</creatorcontrib><identifier>ISSN: 0770-3198</identifier><identifier>EISSN: 1434-9949</identifier><identifier>DOI: 10.1007/s10067-020-05180-7</identifier><identifier>PMID: 32462425</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Antibodies, Antinuclear ; Anticoagulants ; Antinuclear antibodies ; COVID-19 ; Humans ; Impact and specific considerations of COVID-19 for clinical rheumatologists ; Letters of Biomedical and Clinical Research ; Lupus Coagulation Inhibitor ; Medicine ; Medicine & Public Health ; Pneumonia ; Prevalence ; Rheumatology ; RNA, Viral ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Systemic lupus erythematosus</subject><ispartof>Clinical rheumatology, 2020-07, Vol.39 (7), p.2095-2097</ispartof><rights>International League of Associations for Rheumatology (ILAR) 2020</rights><rights>International League of Associations for Rheumatology (ILAR) 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-d7da2bff891e3a81c39d86e0e2e160461bbd1b4caa31847d3a01ae8d837f837b3</citedby><cites>FETCH-LOGICAL-c474t-d7da2bff891e3a81c39d86e0e2e160461bbd1b4caa31847d3a01ae8d837f837b3</cites><orcidid>0000-0001-9974-0735</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10067-020-05180-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10067-020-05180-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51298</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32462425$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gazzaruso, Carmine</creatorcontrib><creatorcontrib>Carlo Stella, Nicoletta</creatorcontrib><creatorcontrib>Mariani, Giuseppe</creatorcontrib><creatorcontrib>Nai, Carlo</creatorcontrib><creatorcontrib>Coppola, Adriana</creatorcontrib><creatorcontrib>Naldani, Daniela</creatorcontrib><creatorcontrib>Gallotti, Pietro</creatorcontrib><title>High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia</title><title>Clinical rheumatology</title><addtitle>Clin Rheumatol</addtitle><addtitle>Clin Rheumatol</addtitle><subject>Antibodies, Antinuclear</subject><subject>Anticoagulants</subject><subject>Antinuclear antibodies</subject><subject>COVID-19</subject><subject>Humans</subject><subject>Impact and specific considerations of COVID-19 for clinical rheumatologists</subject><subject>Letters of Biomedical and Clinical Research</subject><subject>Lupus Coagulation Inhibitor</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pneumonia</subject><subject>Prevalence</subject><subject>Rheumatology</subject><subject>RNA, Viral</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Systemic lupus erythematosus</subject><issn>0770-3198</issn><issn>1434-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU1v1DAQhi0EokvhD3BAlrhwCYw_EjsXpGpFKVKlSi1wtZx4susqawc7qQS_vma3FMqhB9sjzzPvzOgl5DWD9wxAfcjlblQFHCqomYZKPSErJoWs2la2T8kKlIJKsFYfkRc5XwMA1y17To4Elw2XvF6RdOY3WzolvLEjhh5pHKgNsw9LP6JN-7iLzmMuoaPjMi15_9lHu1nGElEf6GRnj2HOdBvz5Gc7-l_o6BATvTq5vKrW8TunU8BlF4O3L8mzwY4ZX929x-Tb6aev67Pq_OLzl_XJedVLJefKKWd5NwxlYhRWs160TjcIyJE1IBvWdY51srdWMC2VExaYRe20UEM5nTgmHw-609Lt0PVlwGRHMyW_s-mnidabh5ngt2YTb4ziNasbKALv7gRS_LFgns3O5x7HsjXGJRsuQdVaQKML-vY_9DouKZT1CsUEFw1XTaH4gepTzDnhcD8MA_PbUnOw1BRLzd5So0rRm3_XuC_542EBxAHIJRU2mP72fkT2FlkjrrU</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Gazzaruso, Carmine</creator><creator>Carlo Stella, Nicoletta</creator><creator>Mariani, Giuseppe</creator><creator>Nai, Carlo</creator><creator>Coppola, Adriana</creator><creator>Naldani, Daniela</creator><creator>Gallotti, Pietro</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9974-0735</orcidid></search><sort><creationdate>20200701</creationdate><title>High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia</title><author>Gazzaruso, Carmine ; Carlo Stella, Nicoletta ; Mariani, Giuseppe ; Nai, Carlo ; Coppola, Adriana ; Naldani, Daniela ; Gallotti, Pietro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-d7da2bff891e3a81c39d86e0e2e160461bbd1b4caa31847d3a01ae8d837f837b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies, Antinuclear</topic><topic>Anticoagulants</topic><topic>Antinuclear antibodies</topic><topic>COVID-19</topic><topic>Humans</topic><topic>Impact and specific considerations of COVID-19 for clinical rheumatologists</topic><topic>Letters of Biomedical and Clinical Research</topic><topic>Lupus Coagulation Inhibitor</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pneumonia</topic><topic>Prevalence</topic><topic>Rheumatology</topic><topic>RNA, Viral</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Systemic lupus erythematosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gazzaruso, Carmine</creatorcontrib><creatorcontrib>Carlo Stella, Nicoletta</creatorcontrib><creatorcontrib>Mariani, Giuseppe</creatorcontrib><creatorcontrib>Nai, Carlo</creatorcontrib><creatorcontrib>Coppola, Adriana</creatorcontrib><creatorcontrib>Naldani, Daniela</creatorcontrib><creatorcontrib>Gallotti, Pietro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gazzaruso, Carmine</au><au>Carlo Stella, Nicoletta</au><au>Mariani, Giuseppe</au><au>Nai, Carlo</au><au>Coppola, Adriana</au><au>Naldani, Daniela</au><au>Gallotti, Pietro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia</atitle><jtitle>Clinical rheumatology</jtitle><stitle>Clin Rheumatol</stitle><addtitle>Clin Rheumatol</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>39</volume><issue>7</issue><spage>2095</spage><epage>2097</epage><pages>2095-2097</pages><issn>0770-3198</issn><eissn>1434-9949</eissn><cop>London</cop><pub>Springer London</pub><pmid>32462425</pmid><doi>10.1007/s10067-020-05180-7</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-9974-0735</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0770-3198 |
| ispartof | Clinical rheumatology, 2020-07, Vol.39 (7), p.2095-2097 |
| issn | 0770-3198 1434-9949 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7251560 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Antibodies, Antinuclear Anticoagulants Antinuclear antibodies COVID-19 Humans Impact and specific considerations of COVID-19 for clinical rheumatologists Letters of Biomedical and Clinical Research Lupus Coagulation Inhibitor Medicine Medicine & Public Health Pneumonia Prevalence Rheumatology RNA, Viral SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Systemic lupus erythematosus |
| title | High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A32%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High%20prevalence%20of%20antinuclear%20antibodies%20and%20lupus%20anticoagulant%20in%20patients%20hospitalized%20for%20SARS-CoV2%20pneumonia&rft.jtitle=Clinical%20rheumatology&rft.au=Gazzaruso,%20Carmine&rft.date=2020-07-01&rft.volume=39&rft.issue=7&rft.spage=2095&rft.epage=2097&rft.pages=2095-2097&rft.issn=0770-3198&rft.eissn=1434-9949&rft_id=info:doi/10.1007/s10067-020-05180-7&rft_dat=%3Cproquest_pubme%3E2413236276%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2413236276&rft_id=info:pmid/32462425&rfr_iscdi=true |